Login / Signup

Chemoproteomic Covalent Ligand Discovery as the PROTAC-gonist: The Future of Targeted Degradation Medicines.

Kyosuke ShishikuraMegan L Matthews
Published in: ACS central science (2024)
Keyphrases
  • small molecule
  • current status
  • cancer therapy
  • high throughput
  • drug delivery